BoneFit: Multimodal Prehabilitation for People Preparing for Orthopaedic Surgery (BoneFit)

June 11, 2024 updated by: University of Hull

BoneFit: A Student-led Multimodal Prehabilitation Service for Orthopaedic Surgical Patients in Hull

To conduct a pilot feasibility study to determine the effect of a student-led prehabilitation service in people awaiting total hip or knee replacement surgery.

Study Overview

Detailed Description

The aim of BoneFit is to provide local people living in the Hull region with a needs-based prehabilitation care package to improve their physical and mental health, quality of life & reduce their length of hospital stay, complications and readmission rates to hospital following orthopaedic surgery (total hip replacement, or total knee replacement.

Currently, Hull University Teaching Hospitals do not offer a prehabilitation service for local patients. The University of Hull will partner with them to provide a student-led multimodal prehabilitation service for referred patients awaiting orthopaedic surgery.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Waiting for unilateral total hip or knee replacement surgery for a minimum of 6 months;
  • Able to provide informed consent;

Exclusion Criteria:

  • Previous hip or knee surgery;
  • Any medical conditions for which moderate to vigorous exercise is contraindicated;
  • Patellar or hip joint instability;
  • Any other disease/condition which severely effects functional performance e.g. stroke or Parkinson's disease;
  • Chronic depression or significant psychiatric disorder;
  • Enrolled in a clinical trial (or recently completed one);
  • Cognitive impairment which would affect compliance to BoneFIt service;
  • Patients unable or unwilling to commit to required study follow-ups
  • Pregnancy;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BoneFit intervention
Participants will receive a personalised care plan comprising exercise, nutrition and psychological wellbeing based on individual need in the 8-week period prior to surgery
Exercise, nutrition and psychological support provided in 8 weeks prior to surgery
Placebo Comparator: Control
Participants who are allocated to this group will receive baseline tests and will be invited to re-attend 3 months post surgery to re-do tests. This group will receive usual care (no intervention). The groups will be compared.
Control group receive usual care (zero intervention)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment
Time Frame: 2 years
Number of people recruited and trained
2 years
Adherence and attendance
Time Frame: 2.5 years
Record the number of sessions attended and calculate adherence to protocol (%)
2.5 years
Acceptability
Time Frame: 3 years
Conduct semi-structured interviews following the intervention with sample of participants and ask them about experiences of the intervention. The post-intervention interviews will focus on how participants viewed the intervention, perceived burdens, and perceived effectiveness from initiation through to completion. A list of burdens / perceived benefits will be reported alongside percentage rates of respondents.
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical fitness
Time Frame: 3 years
Compare incremental shuttle walk test scores (intervention v controls). Units: stage achieved and time taken (seconds)
3 years
Length of stay
Time Frame: 3 years
Compare days in hospital following surgery (intervention v controls). Units: hours in hospital following surgery.
3 years
Readmission rates
Time Frame: 3 years
Compare the % of patients in each group who were readmitted to hospital following surgery (intervention v controls)
3 years
Overall quality of life
Time Frame: 3 years
Compare quality of life scores (intervention v controls) using EQ-5D-5L questionnaire. Index scores range between zero and one, based on 5-point Likert scale, with scores closer to one indicating an improved status.
3 years
Knee or hip specific pain, function and quality of life
Time Frame: 3 years
Compare knee or hip specific quality of life scores (intervention v controls). For knee replacements, the KOOS-12 is scored between 0-100 on 5-point Likert scale, with higher scores equating to improved status. For hip replacements, HOOS-12 scores between 0 to 4 points with 0 representing no hip problems and 4 representing extreme hip problems, based on response to 5-point Likert scale.
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lee Ingle, Professor of Exercise Science for Health and Rehabiliation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 16, 2024

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

March 5, 2024

First Submitted That Met QC Criteria

March 27, 2024

First Posted (Actual)

April 2, 2024

Study Record Updates

Last Update Posted (Actual)

June 12, 2024

Last Update Submitted That Met QC Criteria

June 11, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RS198 - 332551

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Please contact the PI and request access to data

IPD Sharing Time Frame

Dec 2027

IPD Sharing Access Criteria

Request from PI

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orthopedic Disorder

Clinical Trials on Experimental: BoneFit intervention

Subscribe